Roles of macrophages in tumor development: a spatio-temporal perspective

Archive ouverte

Bied, Mathilde | Ho, William | Ginhoux, Florent | Blériot, Camille

Edité par CCSD ; Nature Publishing Group/Chinese Society of Immunology -

International audience.

Macrophages are critical regulators of tissue homeostasis but are also abundant in the tumor microenvironment (TME). In both primary tumors and metastases, such tumorassociated macrophages (TAMs) seem to support tumor development. While we know that TAMs are the dominant immune cell in the TME, their vast heterogeneity and associated functions is only just being unraveled. In this review, we outline the various known TAM populations found thus far, and delineate their specialized roles associated with the main stages of cancer progression. We discuss how macrophages may prime the pre-metastatic niche to enable the growth of a metastasis and then how subsequent metastasis-associated macrophages can support secondary tumor grown. Finally, we speculate on the challenges that remain to be overcome in TAM research.

Suggestions

Du même auteur

Timing and location dictate monocyte fate and their transition to tumor-associated macrophages

Archive ouverte | Dunsmore, Garett | CCSD

International audience. Tumor-associated macrophages (TAMs) are a heterogeneous population of cells whose phenotypes and functions are shaped by factors that are incompletely understood. Herein, we asked when and wh...

Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer

Archive ouverte | Vyhlídalová Kotrbová, Anna | CCSD

International audience. Abstract High‐grade serous carcinoma of the ovary, fallopian tube and peritoneum (HGSC), the most common type of ovarian cancer, ranks among the deadliest malignancies. Many HGSC patients hav...

Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDAC

Archive ouverte | Bidan, Nadège | CCSD

International audience. While considerable efforts have been made to develop new therapies, progress in the treatment of pancreatic cancer has so far fallen short of patients' expectations. This is due in part to th...

Chargement des enrichissements...